Skip to content
Home/Companies/Biotech/Ekinnox
Ekinnox

Ekinnox

Biotech·France·Active
Entry
–
Hold
–
Status
Active

Who owns Ekinnox?

Ekinnox is a French Biotech company, currently owned by Elaia Partners since 2020 and Lazard Elaia Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Lazard Elaia Capital
Most recent investor
Lazard Elaia Capital
Lazard Elaia Capital Fund I · 2025 · Growth
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech
Websitewww.ekinnox.com

Ownership history

2 ownership periods

Active
Co-held by Elaia Partners and Lazard Elaia Capital since 2020.
Elaia Partners
Elaia PartnersActive
2020 · present(6yr) · Elaia DV4 · 2021 · VC
Lazard Elaia Capital
Lazard Elaia CapitalActive
present · Lazard Elaia Capital Fund I · 2025 · Growth

More from Lazard Elaia Capital Fund I

Other portfolio companies in the same fund.

Adomik
Adomik
Active
AdTechFrance
Armis
Armis
Active
AdTechFrance
Arsen
Arsen
Active
CybersecurityFrance
Case Law Analytics
Active
FintechFrance
Cien
Cien
Active
USA
CodeNotary
CodeNotary
Active
CybersecurityUSA

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Ekinnox?

Ekinnox is currently owned by Elaia Partners and Lazard Elaia Capital, through Lazard Elaia Capital Fund I, since 2020.

When did Elaia Partners and 1 other acquire Ekinnox?

Elaia Partners and 1 other acquired Ekinnox in 2020.

Who has owned Ekinnox over time?

Ekinnox has been through 2 private-equity ownership periods: Elaia Partners · via Elaia DV4 · since 2020; Lazard Elaia Capital · via Lazard Elaia Capital Fund I.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue